The Hemophilias — From Royal Genes to Gene Therapy
- 7 June 2001
- journal article
- review article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 344 (23), 1773-1779
- https://doi.org/10.1056/nejm200106073442307
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- Properties of Anti-Factor VIII Inhibitor Antibodies in Hemophilia A PatientsSeminars in Thrombosis and Hemostasis, 2000
- Bleeding episodes in HIV-positive patients taking HIV protease inhibitors: a case seriesHaemophilia, 1999
- MUTATIONS IN A SUBGROUP OF PATIENTS WITH MILD HAEMOPHILIA A AND A FAMILIAL DISCREPANCY BETWEEN THE ONE‐STAGE AND TWO‐STAGE FACTOR VIII:C METHODSBritish Journal of Haematology, 1996
- A new variant of Creutzfeldt-Jakob disease in the UKThe Lancet, 1996
- Effect of grapefruit juice on blood cyclosporin concentrationThe Lancet, 1995
- Factor VIII InhibitorsAnnals of the New York Academy of Sciences, 1987
- Expression of active human factor VIII from recombinant DNA clonesNature, 1984
- Characterization of the human factor VIII geneNature, 1984
- The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIIIThe New England Journal of Medicine, 1981
- Efficacy of Prothrombin-Complex Concentrates in Hemophiliacs with Antibodies to Factor VIIIThe New England Journal of Medicine, 1980